Valuation: Ovation Science Inc.

Market Cap 1.15M 827K 717K 673K 613K 78.92M 1.17M 7.91M 3.09M 39.6M 3.11M 3.04M 132M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 978K 849K 797K 726K 93.36M 1.39M 9.35M 3.65M 46.84M 3.67M 3.59M 156M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.54%
Yield 2024 *
-
Yield 2025 -
1 day+50.00%
1 month+50.00%
Current year-25.00%
1 month 0.02
Extreme 0.02
0.03
Current year 0.02
Extreme 0.015
0.04
1 year 0.02
Extreme 0.015
0.05
3 years 0.01
Extreme 0.01
0.08
5 years 0.01
Extreme 0.01
0.14
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Director of Finance/CFO 63 2023-10-29
Chief Executive Officer 77 2017-10-03
Director TitleAgeSince
Director/Board Member 77 2017-10-03
Director/Board Member 63 2017-10-03
Director/Board Member 86 2018-02-01
Date Insider Type Main position Quantity % Market Cap.
4/7/25 Buy

Director

100,000 0.2642%
1/31/25 Other

Director

0 0%
1/31/25 Buy

Director

100,000 0.2642%
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%-.--%-40.00%-.--% 828K
+0.75%-1.36%+1.04%-7.03% 234B
+1.45%+0.06%+35.27% - 50.56B
+0.63%+11.75%+82.00% - 10.49B
+1.35%+7.86%+36.59%-45.62% 8.73B
-0.88%+2.44%+9.71%+3.14% 5.92B
-0.62%+6.58%-21.16%-30.51% 5.47B
-2.20%-6.40%-0.85%-13.97% 3.78B
-0.59%-0.63%-29.43%-46.19% 3.42B
+0.65%-1.91%-18.55%-48.97% 2.48B
Average +5.05%+0.35%+5.46%-23.64% 32.46B
Weighted average by Cap. +0.77%-1.45%+9.23%-9.57%

Financials

2024 2025
Net sales 113K 81.21K 70.49K 66.16K 60.26K 7.75M 115K 777K 303K 3.89M 305K 299K 12.96M 67.89K 48.7K 42.27K 39.67K 36.13K 4.65M 69.02K 466K 182K 2.33M 183K 179K 7.77M
Net income -456K -327K -284K -267K -243K -31.24M -464K -3.13M -1.22M -15.68M -1.23M -1.2M -52.23M -631K -453K -393K -369K -336K -43.23M -642K -4.33M -1.69M -21.69M -1.7M -1.66M -72.27M
Net Debt 265K 190K 165K 155K 141K 18.16M 270K 1.82M 710K 9.11M 715K 699K 30.36M 211K 151K 131K 123K 112K 14.44M 214K 1.45M 565K 7.24M 568K 556K 24.13M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. OVAT Stock